Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
Epistemonikos ID: 8cb179a38b8727d7b6e675b44feedd24b01f45c3
First added on: Mar 31, 2022